Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 2, 1998
[Radiotherapy of stage T1-T2 M0 prostatic adenocarcinoma. Analysis of the carcinologic results of a multicenter study of 610 patients. Groupe Radiothérapie de la Commission de Coopération Médicale Intercentres (CCMI)]R Rozan, E Albuisson, B Giraud, et al.
Breast (Edinburgh, Scotland)|October 19, 2005
Neoadjuvant endocrine therapy in breast cancerC Abrial, M-A Mouret-Reynier, H Curé, et al.
The British Journal of Surgery|April 13, 2017
Quality of life after mastectomy with or without immediate breast reconstructionJ Dauplat, F Kwiatkowski, P Rouanet, et al.
Presse Medicale (Paris, France : 1983)|January 9, 2001
[Standards, options, and recommendations for initial management of patients with malignant ovarian epithelial tumors]P Kerbrat, C Lhommé, B Fervers, et al.
American Journal of Clinical Oncology|June 1, 1997
Adjuvant chemotherapy with doxorubicin-containing regimen for 326 stage II breast cancers: 15-year resultsJ P Ferrière, S Charrier, H Curé, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1997
Glucocorticoids do not regulate the expression of proteolytic genes in skeletal muscle from Cushing's syndrome patientsC Rallière, I Tauveron, D Taillandier, et al.
Journal De Chirurgie|November 1, 1986
[Ruptured adenoma of the liver with severe pulmonary embolism discovered during a cesarean section]G Aulagnier, A Ramirez, J M Delorme, et al.
Medical Oncology (Northwood, London, England)|August 20, 2005
Tumor parameters, clinical and pathological responses, medical management, and survival through time on 710 operable breast cancersC Abrial, M A Mouret-Reynier, S Amat, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Clinical and pathological response to primary chemotherapy in operable breast cancerP Chollet, S Charrier, E Brain, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|November 21, 2000
[Assessment of different histoprognosis grading systems for primary ovarian cancer: 100 patients given the same treatment for primary ovarian adenocarcinoma]F Penault-Llorca, O Levrel, A Clémenson, et al.
Pageof 19